The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
mTOR is a key modulator of ageing and age-related disease
Open accessAbstract
Many experts in the biology of ageing believe that pharmacological interventions to slow ageing are a matter of 'when' rather than 'if'. A leading target for such interventions is the nutrient response pathway defined by the mechanistic target of rapamycin (mTOR). Inhibition of this pathway extends lifespan in model organisms and confers protection against a growing list of age-related pathologies. Characterized inhibitors of this pathway are already clinically approved, and others are under development. Although adverse side effects currently preclude use in otherwise healthy individuals, drugs that target the mTOR pathway could one day become widely used to slow ageing and reduce age-related pathologies in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the mammalian target of rapamycin (mTOR) pathway, which is induced by amino acids, growth factors, and RT, is often inhibited during CR, and mediates CR-induced health benefits in model organisms [37].”
From Resistance Training Prevents Muscle Loss Induced by Caloric Restriction in Obese Elderly Individuals: A Systematic Review and Meta-Analysis (2018) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a well-known inhibitor of mTOR, rapamycin, inhibits the production of SASP factors”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which might explain its beneficial impact on longevity [121,122].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Genetic down-regulation of mTORC1 activity in yeast, worms and flies extends longevity and attenuates further longevity benefits from DR, suggesting that mTOR inhibition phenocopies DR”
From The Hallmarks of Aging (2013) · cites this paper as Johnson et al., 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inhibition of mTOR has been shown to extend lifespan and to improve the function of ageing organ systems, including the immune system, in multiple preclinical species.18, 19”
From Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials (2021) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“One of the best validated mechanisms underlying ageing biology is the activity of the protein kinase mTOR.”
From Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials (2021) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“More importantly, these pathways have been evaluated in mammalian models, in which health span and lifespan have been extended by genetic manipulation or drugs (Johnson et al., 2013).”
From Metformin as a tool to target aging (2016) · cites this paper as Johnson et al., 2013
In the citing paper
“Of significance is that metformin, like rapamycin, is known to inhibit mTOR signaling, and the inhibition of the mTOR signaling pathway with rapamycin has been shown to extend lifespan in C. elegans, S. cerevisiae, and Drosophila melanogaster (fruit fly) (221–225).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [224]
In the citing paper
“Of significance is that metformin, like rapamycin, is known to inhibit mTOR signaling, and the inhibition of the mTOR signaling pathway with rapamycin has been shown to extend lifespan in C. elegans, S. cerevisiae, and Drosophila melanogaster (fruit fly) (221–225).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [224]
In the citing paper
“Based on previous studies in the aging field, it is believed that Nrf2 is repressed by mTOR pathway (downstream target); therefore, an inhibition of mTOR by rapamycin would increase the activity of Nrf2 (Johnson et al., 2013).”
From Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism (2017) · cites this paper as Johnson et al., 2013
In the citing paper
“The benefits of nicotinamide riboside can be suppressed by treatment of mice with inhibitors of either SIRT1 or mTOR complex 1 (mTORC1), which is paradoxical as inhibition of mTORC1 signalling normally extends healthspan and lifespan220.”
From Ageing and rejuvenation of tissue stem cells and their niches (2023) · cites this paper as [220]
In the citing paper
“The benefits of nicotinamide riboside can be suppressed by treatment of mice with inhibitors of either SIRT1 or mTOR complex 1 (mTORC1), which is paradoxical as inhibition of mTORC1 signalling normally extends healthspan and lifespan220.”
From Ageing and rejuvenation of tissue stem cells and their niches (2023) · cites this paper as [220]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Aging, natural death, and the compression of morbidity
Fries, J. F. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007173030304 · Cited by 3,356
Extending Healthy Life Span—From Yeast to Humans
Fontana, L., Partridge, L., & Longo, V. D. (2010) · Science · doi:10.1126/science.1172539 · Cited by 3,023
Kenyon, C. J. (2010) · Nature · doi:10.1038/nature08980 · Cited by 2,739
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., Allison, D. B., Cruzen, C., Simmons, H. A., Kemnitz, J. W., et al. (2009) · Science · doi:10.1126/science.1173635 · Cited by 2,277
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 1,006
Liver Damage, Inflammation, and Enhanced Tumorigenesis after Persistent mTORC1 Inhibition
Umemura, A., Park, E. J., Taniguchi, K., Lee, J. H., Shalapour, S., Valasek, M. A., Aghajan, M., Nakagawa, H., Seki, E., Hall, M. N., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.001 · Cited by 184
Advances in Understanding of the Role of Lipid Metabolism in Aging
Chung, K. W. (2021) · Cells · doi:10.3390/cells10040880 · Cited by 191
Simpson, D. J., & Chandra, T. (2021) · Aging Cell · doi:10.1111/acel.13452 · Cited by 195
“…ageing, such as mechanistic target of rapamycin (mTOR) and insulin/insulin- like growth factor (IGF) signalling, which can be manipulated to extend lifespan in mammals such as mice (Blüher et al., 2003; Holzenberger et al., 2003; Johnson et al., 2013; Pearson et al., 2008; Weindruch et al., 1986).”
BackgroundMartínez-López, N., Athonvarangkul, D., & Singh, R. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2404-2_3 · Cited by 185
Anti-senescence compounds: A potential nutraceutical approach to healthy aging
Gurău, F., Baldoni, S., Prattichizzo, F., Espinosa, E., Amenta, F., Procopio, A. D., Albertini, M. C., Bonafè, M., & Olivieri, F. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.05.001 · Cited by 179
“Notably, mTOR is a key modulator of aging in organisms as evolutionarily divergent as yeasts and rodents, and it is conceivable that this function is to some extent conserved also in humans (Johnson et al., 2013).”
Gene expression hallmarks of cellular ageing
Frenk, S., & Houseley, J. (2018) · Biogerontology · doi:10.1007/s10522-018-9750-z · Cited by 181
“Particularly, these encompass changes in heat shock proteins and proteases that might be expected to ameliorate the protein aggregation phenotypes associated with cellular ageing (reviewed in Josefson et al. 2017; Kim et al. 2016a; Labbadia and Morimoto 2015a).”
BackgroundMetformin: A Hopeful Promise in Aging Research
Novelle, M. G., Ali, A., Diéguez, C., Bernier, M., & de Cabo, R. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025932 · Cited by 178
Human longevity: Genetics or Lifestyle? It takes two to tango
Passarino, G., Rango, F. D., & Montesanto, A. (2016) · Immunity & Ageing · doi:10.1186/s12979-016-0066-z · Cited by 192
Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment
Rizzo, M. R., Meo, I. D., Polito, R., Auriemma, M. C., Gambardella, A., di Mauro, G., Capuano, A., & Paolisso, G. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106062 · Cited by 193
The dog aging project: translational geroscience in companion animals
Kaeberlein, M. R., Creevy, K. E., & Promislow, D. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9638-7 · Cited by 186
The effects of metformin on autophagy
Lu, G., Wu, Z., Shang, J., Xie, Z., Chen, C., & zhang, C. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111286 · Cited by 188
Yeo, E.-J. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0233-3 · Cited by 175
Cellular Senescence in Cardiovascular Diseases: A Systematic Review
Hu, C., Zhang, X., Teng, T., Ma, Z., & Tang, Q. (2022) · Aging and Disease · doi:10.14336/ad.2021.0927 · Cited by 184
“Previous studies have demonstrated that pharmacological and genetic inhibition of mTOR extended lifespan and delayed the pathogenesis of agingrelated organism dysfunction effectively [131].”
BackgroundProtein synthesis and quality control in aging
Anisimova, A. S., Alexandrov, A. I., Makarova, N. E., Gladyshev, V. N., & Dmitriev, S. E. (2018) · Aging · doi:10.18632/aging.101721 · Cited by 172
“Changes in the mTOR pathway activity during aging is currently an ongoing research direction [132].”
BackgroundShavlakadze, T., Morris, M., Fang, J., Wang, S. X., Zhu, J., Zhou, W., Tse, H. W., Mondragon-Gonzalez, R., Roma, G., & Glass, D. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.043 · Cited by 170
Hino, K., Horigome, K., Nishio, M., Komura, S., Nagata, S., Zhao, C., Jin, Y., Kawakami, K., Yamada, Y., Ohta, A., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93521 · Cited by 168
Regulation of reproduction and longevity by nutrient-sensing pathways
Templeman, N. M., & Murphy, C. T. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201707168 · Cited by 175
“In addition, mTORC1 regulates lipid synthesis, glucose metabolism, and mitochondrial function (Johnson et al., 2013; Saxton and Sabatini, 2017). mTOR therefore integrates information from multiple upstream nutrient and energy sensors to regulate metabolic processes essential for coordinating energy…”
BackgroundInfluentialAging of mesenchymal stem cell: machinery, markers, and strategies of fighting
Al‐Azab, M., Safi, M., Idiiatullina, E., Al‐Shaebi, F., & Zaky, M. Y. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00366-0 · Cited by 178
“dysregulation is involved in aging-related diseases [107, 108].”
Frasca, D., Diaz, A., Romero, M., & Blomberg, B. B. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2016.12.001 · Cited by 160
Molecular mechanisms underlying genotype‐dependent responses to dietary restriction
Schleit, J., Johnson, S. C., Bennett, C. F., Simko, M., Trongtham, N., Castanza, A., Hsieh, E. J., Moller, R. M., Wasko, B. M., Delaney, J. R., et al. (2013) · Aging Cell · doi:10.1111/acel.12130 · Cited by 159
Zhao, D., Yang, J. Z., & Yang, L. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6437467 · Cited by 164
Joseph, G. A., Wang, S. X., Jacobs, C. E., Zhou, W., Kimble, G. C., Tse, H. W., Eash, J. K., Shavlakadze, T., & Glass, D. J. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00141-19 · Cited by 158
“Among these signaling pathways, genetic or pharmacological inhibition of mammalian target of rapamycin complex 1 (mTORC1) is thus far the best-validated intervention to delay age-related pathophysiological changes (11).”
BackgroundMitochondrial Proteostasis in the Control of Aging and Longevity
Jensen, M. B., & Jasper, H. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.006 · Cited by 169
Hernández‐Aguilera, A., Rull, A., Rodríguez‐Gallego, E., Riera-Borrull, M., Luciano‐Mateo, F., Camps, J., Menéndez, J. A., & Joven, J. (2013) · Mediators of Inflammation · doi:10.1155/2013/135698 · Cited by 167
Turning back time with emerging rejuvenation strategies
Mahmoudi, S., Xu, L., & Brunet, A. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0206-0 · Cited by 171
Optimal body weight for health and longevity: bridging basic, clinical, and population research
Fontana, L., & Hu, F. B. (2014) · Aging Cell · doi:10.1111/acel.12207 · Cited by 157
Peng, N., Meng, N., Wang, S., Zhao, F. L., Zhao, J., Su, L., Zhang, S., Zhang, Y. L., Zhao, B., & Miao, J. (2014) · Scientific Reports · doi:10.1038/srep05519 · Cited by 161
Dietary Restriction Extends Lifespan through Metabolic Regulation of Innate Immunity
Wu, Z., Isik, M., Moroz, N., Steinbaugh, M. J., Zhang, P., & Blackwell, T. K. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.013 · Cited by 163
“From yeast to mammals, lifespan can be extended through inhibition of the mTORC1 (mechanistic target of rapamycin complex 1) kinase, a driver of growth that integrates amino acid and growth factor signals (Fontana and Partridge, 2015; Greer and Brunet, 2009; Johnson et al., 2013; Kapahi et al., 2017; Kenyon, 2010).”
Is Chronic Obstructive Pulmonary Disease an Accelerated Aging Disease?
MacNee, W. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201602-124aw · Cited by 153
New targets for rapid antidepressant action
Machado‐Vieira, R., Henter, I. D., & Zarate, C. A. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.001 · Cited by 161
Rejuvenating Strategies for Stem Cell-Based Therapies in Aging
Neves, J., Sousa‐Victor, P., & Jasper, H. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.01.008 · Cited by 160
Lean, S. C., Heazell, A. E. P., Dilworth, M. R., Mills, T. A., & Jones, R. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-09814-w · Cited by 160
Azpurua, J., Ke, Z., Chen, I. X., Zhang, Q., Ermolenko, D. N., Zhang, Z. D., Gorbunova, V. A., & Seluanov, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313473110 · Cited by 160
Dietary and Metabolic Control of Stem Cell Function in Physiology and Cancer
Mihaylova, M. M., Sabatini, D. M., & Yilmaz, Ö. H. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.008 · Cited by 158
Owusu-Ansah, E., & Perrimon, N. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.012989 · Cited by 156
TOR Signaling in Caenorhabditis elegans Development, Metabolism, and Aging
Blackwell, T. K., Sewell, A. K., Wu, Z., & Han, M. (2019) · Genetics · doi:10.1534/genetics.119.302504 · Cited by 148
“elegans, Drosophila, and female mice (Selman et al. 2009; Fontana et al. 2010; Johnson et al. 2013).”
BackgroundResultInfluentialAlterations of the translation apparatus during aging and stress response
Gonskikh, Y., & Polacek, N. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.04.003 · Cited by 140
Mitochondrial dysfunction in cardiac aging
Tocchi, A., Quarles, E. K., Basisty, N., Gitari, L., & Rabinovitch, P. S. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.07.009 · Cited by 154
Unraveling the Truth About Antioxidants: ROS and disease: finding the right balance
Kawagishi, H., & Finkel, T. (2014) · Nature Medicine · doi:10.1038/nm.3625 · Cited by 152
Branched-chain amino acid catabolism is a conserved regulator of physiological ageing
Mansfeld, J., Urban, N., Priebe, S., Groth, M., Frahm, C., Hartmann, N., Gebauer, J., Ravichandran, M., Dommaschk, A., Schmeisser, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms10043 · Cited by 151
Babu, H., Ambikan, A. T., Gabriel, E. E., Akusjärvi, S. S., Palaniappan, A. N., Sundaraj, V., Mupanni, N. R., Sperk, M., Cheedarla, N., Sridhar, R., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01965 · Cited by 150
“Proteins like 4E-BP1 and the association of mTOR with aging and age-related diseases (31, 32), has already been documented.”
BackgroundThe role of cellular senescence and SASP in tumour microenvironment
Takasugi, M., Yoshida, Y., Hara, E., & Ohtani, N. (2023) · The FEBS Journal · doi:10.1111/febs.16381 · Cited by 144
Improving Precursor Selectivity in Data-Independent Acquisition Using Overlapping Windows
Amodei, D., Egertson, J. D., MacLean, B., Johnson, R. S., Merrihew, G. E., Keller, A., Marsh, D., Vitek, O., Mallick, P., & MacCoss, M. J. (2019) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-018-2122-8 · Cited by 143
“Rapamycin acts by attenuating target-of-rapamycin (TOR) signaling, causing downstream effects such as reduced protein synthesis, resistance to stress, increased autophagy, and changes in mitochondrial metabolism [16].”
BackgroundRationally designed rapamycin-encapsulated ZIF-8 nanosystem for overcoming chemotherapy resistance
Xu, M., Hu, Y. B., Ding, W., Li, F., Lin, J., Wu, M., Wu, J., Wen, L., Qiu, B., Wei, P., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120308 · Cited by 145
Fok, W. C., Chen, Y., Bokov, A. F., Zhang, Y., Salmon, A. B., Diaz, V., Javors, M. A., Wood, W. H., Zhang, Y., Becker, K. G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083988 · Cited by 147
Ge, D., Han, L., Huang, S., Peng, N., Wang, P., Jiang, Z., Zhao, J., Su, L., Zhang, S., Zhang, Y., et al. (2014) · Autophagy · doi:10.4161/auto.28363 · Cited by 146
Genetic and epigenetic regulation of human aging and longevity
Morris, B. J., Willcox, B. J., & Donlon, T. A. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.039 · Cited by 140
Anti-aging pharmacology: Promises and pitfalls
Vaiserman, A. M., Lushchak, O. V., & Koliada, A. K. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.08.004 · Cited by 148
O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle
Hanover, J. A., Chen, W., & Bond, M. R. (2018) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-018-9751-2 · Cited by 144
Bartolomé, A., García-Aguilar, A., Asahara, S.-I., Kido, Y., Guillén, C., Pajvani, U. B., & Benito, M. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00441-17 · Cited by 141
“These data may be relevant to a host of pathophysiologic metabolic and neoplastic conditions that have been linked to both abnormal MTORC1 signaling (40) and mitochondrial function (41) or uncoupling (42).”
BackgroundBlagosklonny, M. V. (2013) · Cell Cycle · doi:10.4161/cc.27188 · Cited by 148
Kumar, R., Sharma, A., Kumari, A., Gulati, A., Padwad, Y. S., & Sharma, R. (2018) · Biogerontology · doi:10.1007/s10522-018-9785-1 · Cited by 143
Fasting enhances cold resistance in fish through stimulating lipid catabolism and autophagy
Lu, D., Ma, Q., Wang, J., Li, L., Han, S., Limbu, S. M., Li, D., Chen, L., Zhang, M., & Du, Z. (2019) · The Journal of Physiology · doi:10.1113/jp277091 · Cited by 148
“…is consensus that, in mammals, the positive effect of dietary restriction in causing life extension is probably correlated with a reduced mTOR signalling pathway (Miller et al. 2014), and its repression also plays positive roles in resisting multiple environmental stresses (Johnson et al. 2013).”
BackgroundInfluentialKirkman, D. L., Robinson, A. T., Rossman, M. J., Seals, D. R., & Edwards, D. G. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00917.2020 · Cited by 150
Antiaging diets: Separating fact from fiction
Lee, M. B., Hill, C. M., Bitto, A., & Kaeberlein, M. R. (2021) · Science · doi:10.1126/science.abe7365 · Cited by 147
“Both complexes are affected by nutrient and growth cues, but mTORC1 has received the most scrutiny owing to observations that its inhibition is sufficient to mimic the effects of CR on life span in yeast, worms, flies, andmice (82).”
A Drosophila model of closed head traumatic brain injury
Katzenberger, R. J., Loewen, C. A., Wassarman, D. R., Petersen, A. J., Ganetzky, B., & Wassarman, D. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316895110 · Cited by 143
Relaxed Selection Limits Lifespan by Increasing Mutation Load
Cui, R., Medeiros, T., Willemsen, D., Iasi, L. N. M., Collier, G. E., Graef, M., Reichard, M., & Valenzano, D. R. (2019) · Cell · doi:10.1016/j.cell.2019.06.004 · Cited by 140
Sardeli, A. V., Komatsu, T. R., Mori, M. A., Gáspari, A. F., & Chacon-Mikahil, M. P. T. (2018) · Nutrients · doi:10.3390/nu10040423 · Cited by 138
“However, while chronic mTOR activation during obesity or aging might be deleterious [37], like in CRRT, mTOR activation concurrent with decreased energy balance may preserve protein synthesis, while stimulating fat depletion.”
BackgroundRole of the inflammation-autophagy-senescence integrative network in osteoarthritis
Vinatier, C., Domínguez, E., Guicheux, J., & Caramés, B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00706 · Cited by 135
“Other processes including the regulation of protein synthesis, regulation of mitochondrial function, anti-inflammatory effects, increased stress resistance and preservation of stem-cells might also contribute to the prolongevity effects of mTOR inhibition (Johnson et al., 2013).”
BackgroundDietary restriction.; mitochondrial function and aging: From yeast to humans
Ruetenik, A., & Barrientos, A. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.05.005 · Cited by 139
Hartman, N. W., Lin, T. V., Zhang, L., Paquelet, G. E., Feliciano, D. M., & Bordey, A. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.017 · Cited by 141
The Circadian Protein Period2 Suppresses mTORC1 Activity via Recruiting Tsc1 to mTORC1 Complex
Wu, R., Dang, F., Li, P., Wang, P., Xu, Q., Liu, Z., Li, Y., Wu, Y., Chen, Y., & Liu, Y. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.11.006 · Cited by 138
Sadria, M., & Layton, A. T. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00706-1 · Cited by 150
“We conduct simulations to investigate the molecular mechanisms underlying the effects of rapamycin and its interactions with other mTORC1 inhibitors [28].”
BackgroundZheng, X., Boyer, L. F., Jin, M., Kim, Y., Fan, W., Bardy, C., Berggren, W. T., Evans, R. M., Gage, F. H., & Hunter, T. R. (2016) · eLife · doi:10.7554/elife.13378 · Cited by 139
The flavonoid 4,4′-dimethoxychalcone promotes autophagy-dependent longevity across species
Carmona‐Gutiérrez, D., Zimmermann, A., Kainz, K., Pietrocola, F., Chen, G., Maglioni, S., Schiavi, A., Nah, J., Mertel, S., Beuschel, C. B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08555-w · Cited by 138
Inflammaging as a target for healthy ageing
Dugan, B., Conway, J., & Duggal, N. A. (2023) · Age and Ageing · doi:10.1093/ageing/afac328 · Cited by 154
A Ribosomal Perspective on Proteostasis and Aging
Steffen, K. K., & Dillin, A. G. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.013 · Cited by 135
Polis, B., & Samson, A. O. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.274328 · Cited by 142
“Of note, inhibition of the mTOR pathway prolongs the lifetime of various organisms and protects against age-related pathologies, including AD (Johnson et al., 2013).”
Chronic Inflammation in the Context of Everyday Life: Dietary Changes as Mitigating Factors
Margina, D. M., Ungurianu, A., Purdel, C. N., Tsoukalas, D., Sarandi, E., Thanasoula, M., Tekos, F., Mesnage, R., Kouretas, D., & Tsatsakis, A. M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17114135 · Cited by 146
de Pablos, R. M., Espinosa‐Oliva, A. M., Ortega, R. H., Cano, M., & Argüelles, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.005 · Cited by 140
Wang, N., Luo, Z., Jin, M., Sheng, W., Wang, H.-T., Long, X., Wu, Y., Hu, P., Xu, H. A., & Zhang, X. (2019) · Aging · doi:10.18632/aging.101966 · Cited by 149
“Both autophagy and mitophagy are regulated by the protein kinase B (Akt)/mTOR pathway [9, 16].”
BackgroundInfluentialRoles of mTOR Signaling in Tissue Regeneration
Wei, X., Luo, L., & Chen, J.-Z. (2019) · Cells · doi:10.3390/cells8091075 · Cited by 136
“In the 1970s, a new antifungal, was discovered in soil samples on the Polynesian island of Rapa Nui, which was isolated from Streptomyces hygroscopicus and called rapamycin [1,2].”
BackgroundPrattichizzo, F., De Nigris, V., La Sala, L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1810327 · Cited by 129
Targeting the mTOR Signaling Network for Alzheimer’s Disease Therapy
Wang, C., Yu, J., Miao, D., Wu, Z., Tan, M., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8505-8 · Cited by 136
Morgan, A. E., Mooney, K. M., Wilkinson, S. J., Pickles, N. A., & Auley, M. T. M. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.03.008 · Cited by 145
The mTOR–S6K pathway links growth signalling to DNA damage response by targeting RNF168
Xie, X., Hu, H., Tong, X., Li, L., Liu, X., Chen, M., Yuan, H., Xie, X., Li, Q., Zhang, Y., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-017-0033-8 · Cited by 132
“mTOR, the central modulator of cellular homeostasis, has been implicated in genome integrity maintenance, and accumulated evidences have suggested that mTOR inhibition by nutrients and caloric restriction contributes to cancer prevention and extended lifespan 9, 10, 17 .”
Dysregulated metabolic pathways in age-related macular degeneration
Zhang, M., Jiang, N., Chu, Y., Postnikova, O. A., Varghese, R. S., Horvath, A., Cheema, A. K., & Golestaneh, N. (2020) · Scientific Reports · doi:10.1038/s41598-020-59244-4 · Cited by 135
Increased fidelity of protein synthesis extends lifespan
Martinez-Miguel, V. E., Lujan, C., Espie--Caullet, T., Martinez-Martinez, D., Moore, S., Backes, C., Gonzalez, S., Galimov, E. R., Brown, A. E. X., Halic, M., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.017 · Cited by 137
“Interestingly, it was shown that one of the most well-studied anti-aging drugs, the mTOR inhibitor rapamycin (Johnson et al., 2013), reduces errors in translation in mammalian cells in vitro (Conn and Qian, 2013; Xie et al.”
BackgroundCaloric restriction and cancer: molecular mechanisms and clinical implications
Meynet, O., & Ricci, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.05.001 · Cited by 143
The genetics of human longevity: an intricacy of genes, environment, culture and microbiome
Dato, S., Rose, G., Crocco, P., Monti, D., Garagnani, P., Franceschi, C., & Passarino, G. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.03.011 · Cited by 135
Mediterranean diet and the hallmarks of ageing
Shannon, O. M., Ashor, A. W., Scialò, F., Saretzki, G. C., Martin-Ruiz, C. M., Lara, J., Matu, J., Griffiths, A., Robinson, N., Lionetti, L., et al. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-00841-x · Cited by 136
A pharmacological network for lifespan extension in C aenorhabditis elegans
Ye, X., Linton, J. M., Schork, N. J., Buck, L. B., & Petrascheck, M. (2013) · Aging Cell · doi:10.1111/acel.12163 · Cited by 132
Mannick, J. B., Teo, G., Bernardo, P., Quinn, D., Russell, K., Klickstein, L., Marshall, W., & Shergill, S. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00062-3 · Cited by 131
Stout, M. B., Steyn, F. J., Jurczak, M. J., Camporez, J.-P. G., Zhu, Y., Hawse, J. R., Jurk, D., Palmer, A. K., Xu, M., Pirtskhalava, T., et al. (2017) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv309 · Cited by 119
EPRS is a critical mTORC1–S6K1 effector that influences adiposity in mice
Arif, A., Terenzi, F., Potdar, A. A., Jia, J., Sacks, J., China, A., Halawani, D., Vasu, K., Li, X., Brown, J. M., et al. (2017) · Nature · doi:10.1038/nature21380 · Cited by 128
Gu, Z., Tan, W., Ji, J., Feng, G., Meng, Y., Da, Z., Guo, G., Xia, Y., Zhu, X., Shi, G., et al. (2016) · Aging · doi:10.18632/aging.100925 · Cited by 129
Drugs that modulate aging: the promising yet difficult path ahead
Kennedy, B. K., & Pennypacker, J. K. (2014) · Translational research · doi:10.1016/j.trsl.2013.11.007 · Cited by 127
The mitochondrial ATP synthase is a shared drug target for aging and dementia
Goldberg, J., Currais, A. J. M., Prior, M., Fischer, W. H., Chiruta, C., Ratliff, E. P., Daugherty, D., Dargusch, R., Finley, K. D., Esparza‐Moltó, P. B., et al. (2018) · Aging Cell · doi:10.1111/acel.12715 · Cited by 131
Cellular reprogramming and epigenetic rejuvenation
Simpson, D. J., Olova, N. N., & Chandra, T. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01158-7 · Cited by 127
(2024) · doi:10.1016/j.cmet.2024.01.015 · Cited by 119
Chronic inflammation and sarcopenia: A regenerative cell therapy perspective
Chhetri, J. K., Barreto, P. D. S., Fougère, B., Rolland, Y., Vellas, B. J., & Cesari, M. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.12.023 · Cited by 129
“…of the mTOR pathway was found to reduce fibrosis and inflammation, increase muscle fiber size in a muscular dystrophy murine model (Foltz et al., 2016), increase life-span in worms, and thought to have possibilities of delaying age-associated pathologies (such as sarcopenia) (Johnson et al., 2013).”
BackgroundAutophagy in health and disease: From molecular mechanisms to therapeutic target
Lu, G. X., Wang, Y., Shi, Y. P., Zhang, Z., Huang, C., He, W., Wang, C., & Shen, H. (2022) · MedComm · doi:10.1002/mco2.150 · Cited by 135
Immunology of the ageing kidney
Sato, Y., & Yanagita, M. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0185-9 · Cited by 126
Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity
Tsai, S., Sitzmann, J. M., Dastidar, S. G., Rodriguez, A. A., Vu, S. L., McDonald, C. E., Academia, E. C., O’Leary, M. N., Ashe, T. D., La Spada, A. R., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77361 · Cited by 126
Yasuda, M., Tanaka, Y., Kume, S., Morita, Y., Chin-Kanasaki, M., Araki, H., Isshiki, K., Araki, S.-I., Koya, D., Haneda, M., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.001 · Cited by 123
Hydrogen sulfide and autophagy: A double edged sword
Wu, D., Wang, H., Teng, T., Duan, S., Ji, A., & Li, Y. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.002 · Cited by 124
Caloric restriction: Beneficial effects on brain aging and Alzheimer’s disease
Van Cauwenberghe, C., Vandendriessche, C., Libert, C., & Vandenbroucke, R. E. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9647-6 · Cited by 121
Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic
Moskalev, A., Chernyagina, E., Tsvetkov, V. O., Fedintsev, A., Shaposhnikov, M. V., Krutko, V. N., Zhavoronkov, A. A., & Kennedy, B. K. (2016) · Aging Cell · doi:10.1111/acel.12463 · Cited by 128
Shobin, E., Bowley, M. P., Estrada, L. I., Heyworth, N. C., Orczykowski, M. E., Eldridge, S. A., Calderazzo, S. M., Mortazavi, F., Moore, T. L., & Rosene, D. L. (2017) · GeroScience · doi:10.1007/s11357-017-9965-y · Cited by 126
Cohen, R. A., Marsiske, M., & Smith, G. E. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00010-8 · Cited by 150
Metadata
- Authors
- Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M.
- Affiliations
- University of Washington (US)
- Guangdong Medical College (CN)
- Corresponding author
- Kaeberlein, Matt
- Venue
- Nature
- Published
- 2013-01-16
- Volume
- 493
- Issue
- 7432
- Pages
- 338-345
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3687363
- OpenAlex
- W2010583480
- Cited by
- 1,676
- References
- 100
- Citations by year
- 2026: 87 · 2025: 82 · 2024: 117 · 2023: 121 · 2022: 113 · 2021: 164 · 2020: 136 · 2019: 140 · 2018: 125 · 2017: 133 · 2016: 136 · 2015: 119 · 2014: 131 · 2013: 72
- FWCI
- 9.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG031108, T32AG000057, P01AG001751, R01AG039390, R01AG038550, P30AG013280)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- mTOR, aging, age-related diseases, lifespan extension, rapamycin, mTOR inhibitors, pharmacological interventions
- MeSH terms
- Aging, Animals, Humans, Insulin, Insulin-Like Growth Factor I, Longevity, Signal Transduction, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
